Summary of Significant Accounting Policies - Research and Development Expenditure (Details) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Summary of Significant Accounting Policies | |||
| Acquired in-process R&D expensed | $ 562,000 | $ 889,000 | $ 4,556,000 |
| Reimbursement of Research and Development Tax and Expenditure Credit | $ 34,082,000 | $ 19,442,000 | $ 18,649,000 |
| X | ||||||||||
- Definition Reimbursement Of research and development tax and expenditure credit. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of the write-off for research and development assets that were acquired in a transaction other than a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|